BRISIGOTTI, VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 3.837
EU - Europa 1.625
AS - Asia 1.452
SA - Sud America 326
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 114
OC - Oceania 1
Totale 7.516
Nazione #
US - Stati Uniti d'America 3.757
SG - Singapore 482
IT - Italia 359
VN - Vietnam 330
CN - Cina 308
RU - Federazione Russa 266
BR - Brasile 259
FR - Francia 168
SE - Svezia 148
DE - Germania 137
IE - Irlanda 135
UA - Ucraina 129
HK - Hong Kong 101
GB - Regno Unito 81
FI - Finlandia 71
CI - Costa d'Avorio 56
IN - India 53
CA - Canada 38
BD - Bangladesh 37
TR - Turchia 36
DK - Danimarca 34
ZA - Sudafrica 30
MX - Messico 25
NL - Olanda 24
AR - Argentina 22
JP - Giappone 18
KR - Corea 17
MA - Marocco 17
IQ - Iraq 16
ES - Italia 15
BE - Belgio 14
PL - Polonia 13
EC - Ecuador 11
CL - Cile 10
PK - Pakistan 10
ID - Indonesia 7
JM - Giamaica 7
VE - Venezuela 7
AT - Austria 6
PY - Paraguay 6
UZ - Uzbekistan 6
CO - Colombia 5
EG - Egitto 5
PH - Filippine 5
CZ - Repubblica Ceca 4
HU - Ungheria 4
TH - Thailandia 4
CH - Svizzera 3
EU - Europa 3
HR - Croazia 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
GT - Guatemala 2
JO - Giordania 2
KE - Kenya 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
SM - San Marino 2
UY - Uruguay 2
AI - Anguilla 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
IL - Israele 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LB - Libano 1
LC - Santa Lucia 1
LY - Libia 1
MT - Malta 1
NI - Nicaragua 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 7.358
Città #
Ashburn 556
Chandler 372
Singapore 310
Dallas 224
Des Moines 186
Fairfield 173
San Jose 172
Council Bluffs 157
Jacksonville 142
Dublin 135
New York 118
Boardman 114
Ho Chi Minh City 99
Hong Kong 96
Wilmington 86
Hanoi 85
Seattle 83
The Dalles 83
Woodbridge 74
Houston 70
Beijing 67
Los Angeles 63
Cambridge 60
Munich 58
Abidjan 55
Lawrence 52
Princeton 52
Ann Arbor 50
Lauterbourg 50
Moscow 45
San Mateo 41
Helsinki 35
Centro 31
São Paulo 27
Buffalo 26
Turin 26
London 24
Milan 24
Santa Clara 24
Turku 24
Ancona 23
Orem 23
Shanghai 23
Pune 22
San Diego 22
Chicago 20
Da Nang 20
Guangzhou 19
Haiphong 18
Johannesburg 18
Hefei 16
Chennai 14
Rome 14
Tolentino 14
Brooklyn 13
Brussels 13
Denver 13
Marche 13
Tokyo 13
Wuhan 13
Phoenix 12
Montreal 11
Poplar 10
Warsaw 10
Washington 10
Atlanta 9
Miano 9
Ascoli Piceno 8
Boston 8
Frankfurt am Main 8
Hải Dương 8
Manchester 8
Stockholm 8
Baghdad 7
Biên Hòa 7
Columbus 7
Menlo Park 7
Norwalk 7
Nuremberg 7
San Francisco 7
Cagliari 6
Guarulhos 6
Kilburn 6
Piscataway 6
Rio de Janeiro 6
Campinas 5
Cape Town 5
Curitiba 5
Huskvarna 5
Itaquaquecetuba 5
Salt Lake City 5
San Bernardo 5
Surrey 5
Toronto 5
Wuxi 5
Amsterdam 4
Bắc Ninh 4
Can Tho 4
Gainesville 4
Genoa 4
Totale 4.781
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 330
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 241
I polimorfismi genetici nel melanoma cutaneo 225
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 168
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 160
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 157
Involvement of the oral cavity in psoriasis: results of a clinical study 156
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 156
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 152
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 151
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 149
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 144
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 143
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 141
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 140
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 140
Dermoscopic features of conjunctival melanocytic lesions 139
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 136
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 135
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 134
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 131
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 130
The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region 130
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 130
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 129
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 127
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 127
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 122
Reticulated acanthoma with sebaceous differentiation 122
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 122
The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients 121
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 121
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 120
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 119
Relapsing acute generalized exanthematous pustolosis: a guess. 118
Topical application of fumaric acid esters improves appearance of nail psoriasis 117
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 116
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 116
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 114
Mycosis Fungoides-like Eruption and Infliximab 113
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 113
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 113
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 112
The switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group 111
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 111
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 109
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 109
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 108
Expression of nicotinamide N-methyltransferase in non-melanoma skin cancers 107
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 105
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 101
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 98
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 97
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 96
Phototherapy in Dermatology 89
Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa 78
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 70
Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation. 47
Totale 7.516
Categoria #
all - tutte 36.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022413 0 75 22 9 16 24 12 40 23 11 72 109
2022/20231.054 81 125 82 89 56 273 3 57 193 5 68 22
2023/2024601 89 11 57 63 71 141 11 27 4 43 7 77
2024/20251.014 155 81 29 19 39 40 88 33 202 67 140 121
2025/20263.049 289 169 238 310 374 212 508 261 249 217 86 136
2026/2027223 160 63 0 0 0 0 0 0 0 0 0 0
Totale 7.516